Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.
作者信息
Kontopoulou-Griva I, Hatzidimitriou-Papazacharia K, Spiliotopoulou J, Tsagarakis N, Digenopoulou E
机构信息
1st Regional Transfusion Center, Hippokration Hospital, Athens, Greece.
出版信息
Birth Defects Orig Artic Ser. 1988;23(5B):111-6.
PMID:3390532
Abstract
摘要
相似文献
1
Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.
Birth Defects Orig Artic Ser. 1988;23(5B):111-6.
2
[Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
Pediatria (Napoli). 1983 Oct-Dec;91(4):371-7.
3
[Thalassemia major: chelating therapy with deferoxamine].
Medicina (B Aires). 1985;45(3):231-4.
4
[Desferrioxamine B treatment of 4 splenectomized cases of Cooley's anemia].
Riv Clin Pediatr. 1968 Sep-Oct;81(5):1002-9.
5
Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients.
Am J Pediatr Hematol Oncol. 1983 Spring;5(1):73-7.
6
Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.
Birth Defects Orig Artic Ser. 1982;18(7):347-53.
7
The simple rubber band technic for slow subcutaneous infusion of desferrioxamine.
J Med Assoc Thai. 1984 Feb;67(2):89-92.
8
Subcutaneous diethylene triamine pentaacetic acid: comparison with desferrioxamine in thalassemic patients with iron overload.
Birth Defects Orig Artic Ser. 1988;23(5B):105-9.
9
Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
Haematologica. 1981 Apr;66(2):196-207.
10
[Desferrioxamine in thalassemia].
Harefuah. 1983 May 15;104(10):438-40.
Zotero 插件